Precisely why NOX4 and the antioxidant defense response may decline in NASH and fibrosis remains unclear, but may relate to the mitochondrial dysfunction associated with advanced disease (9, 10, 72). The gene discussed is NOX4; the disease is metabolic dysfunction-associated steatohepatitis.